# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001829126-23-002504
Filing Date
2023-03-31
Accepted
2023-03-31 16:30:49
Documents
66
Period of Report
2022-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-K | titanpharma_10k.htm iXBRL | 10-K | 1223011
2 | EXHIBIT 23.1 | titanpharma_ex23-1.htm | EX-23.1 | 4145
3 | EXHIBIT 31.1 | titanpharma_ex31-1.htm | EX-31.1 | 16260
4 | EXHIBIT 32.1 | titanpharma_ex32-1.htm | EX-32.1 | 8212
| Complete submission text file | 0001829126-23-002504.txt |  | 5143681

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL SCHEMA FILE | ttnp-20221231.xsd | EX-101.SCH | 38974
6 | XBRL CALCULATION FILE | ttnp-20221231_cal.xml | EX-101.CAL | 51025
7 | XBRL DEFINITION FILE | ttnp-20221231_def.xml | EX-101.DEF | 137802
8 | XBRL LABEL FILE | ttnp-20221231_lab.xml | EX-101.LAB | 319025
9 | XBRL PRESENTATION FILE | ttnp-20221231_pre.xml | EX-101.PRE | 251937
60 | EXTRACTED XBRL INSTANCE DOCUMENT | titanpharma_10k_htm.xml | XML | 697585

Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 6502444990
TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)

EIN.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-13341 | Film No.: 23788295
SIC: 2836 Biological Products, (No Diagnostic Substances)